EHS - 46 Cancer Treatment Procedures Included in AP Employee Health Scheme GO 1. HM & FW Department – Employees Health Scheme- Inclusion of (46) Cancer Care procedures under Employees Health Scheme on par with Aarogyasri scheme for getting the treatment in the empanelled network hospitals initially for a period of one year –Orders- Issued. HEALTH, MEDICAL & FAMILY WELFARE (I.1) DEPARTMENT G.O.MS.No. 1 Dated: 07-01-2021.
1. G.O.Ms.No.174 , HM&FW (M2) Dept , dated 01-11-2013.
2. G.O.Ms.No.175, HM&FW (M2) Dept, dated 01-11-2013.
3. G.O.Ms.No.176, HM&FW (M2) Dept, dated 01-11-2013.
4. G.O.Ms.No.26, HM&FW (M2) Dept , dated 05-02-2014.
5. G.O.Ms.No.134, HM&FW(I.1) Dept, dated:29 -10-2014.
6. From the CEO, Dr.YSRAHCT,Guntur,Lr.Rc.No.Dr.YSR AHCT/ EHS/910/2020, Dt:28-10-2020.
ORDER:
EHS - 46 Cancer Treatment Procedures Included in AP Employee Health Scheme GO 1
Read the following :-1. G.O.Ms.No.174 , HM&FW (M2) Dept , dated 01-11-2013.
2. G.O.Ms.No.175, HM&FW (M2) Dept, dated 01-11-2013.
3. G.O.Ms.No.176, HM&FW (M2) Dept, dated 01-11-2013.
4. G.O.Ms.No.26, HM&FW (M2) Dept , dated 05-02-2014.
5. G.O.Ms.No.134, HM&FW(I.1) Dept, dated:29 -10-2014.
6. From the CEO, Dr.YSRAHCT,Guntur,Lr.Rc.No.Dr.YSR AHCT/ EHS/910/2020, Dt:28-10-2020.
- In the reference 1st read above, the Chief Executive Officer (CEO), Dr.YSR Aarogyasri Health Care Trust (AHCT), Guntur has furnished proposals for inclusion of the following (46) new cancer care procedures pertaining to (3) specialities, under Employees Health Scheme (EHS) on par with Aarogyasri scheme for getting the treatment in the empanelled network hospitals, to the benefit of Employees, Pensioners and their dependent family members.
| S.No | Specialty Name | No.of new procedures |
| 1 | Surgical Oncology | 10 |
| 2 | Medical Oncology | 32 |
| 3 | Radiation Oncology | 4 |
| Total | 46 | |
- 2. Government after careful examination of the matter, hereby include (46) new Cancer Care procedures under EHS on par with Aarogyasri scheme in the empanelled Network Hospitals for a initial period of one year from the date of issue of order. The list of (46) new procedures included in the EHS is annexed to this order.
- 3. The CEO., Dr.YSR AHCT shall send necessary proposals for renewal after completion of one year from the date of issue of order, duly furnishing the expenditure incurred towards (46) new procedures in the EHS.
- 4. The CEO., Dr.YSR AHCT shall take further necessary action in the matter accordingly.
- 5. This order issues with the concurrence of Finance (FMU-HM&FW)Dept, vide their U.O.No.FMU0PC(HMF1)/342/FMU.HM&FW/2020,(Computer No:1302702), Dated. 24/12/2020.
ANNEXURE
| S.No | Procedure Name | Type | Specialty Name |
Package Amount
|
| 1 | External carotid artery ligation | IP | SURGICAL ONCOLOGY | 25000 |
| 2 | Tracheal Stenting | IP | SURGICAL ONCOLOGY | 70000 |
| 3 | Stapplers in Bowel Resection and anastomosis | IP | SURGICAL ONCOLOGY | 35000 |
| 4 | Bronchoscopic Tumor Resection |
IP | SURGICAL ONCOLOGY | 85000 |
| 5 | Laproscopic radical cystectomy with Ilealconduit diversion |
IP | SURGICAL ONCOLOGY | 90000 |
| 6 | Reconstruction with OsscoMyoCutaneous flap |
IP | SURGICAL ONCOLOGY | 70000 |
| 7 | Revision Surgeries for Flap necrosis | IP | SURGICAL ONCOLOGY | 35000 |
| 8 | Chemo port (Below 13 years age group) + EWS + Breast cancer patients + folfox patients. | IP | SURGICAL ONCOLOGY | 40000 |
| 9 | Surgical Management of Post OperativeAnastamotic leak |
IP | SURGICAL ONCOLOGY | 40000 |
| 10 | ExtrapleuralPneumonectomies | IP | SURGICAL ONCOLOGY | 90000 |
| 11 |
Relapse Hodgekin Lymphoma Protocol - ICE/DHAP - 3 cycles are allowed |
IP | MEDICAL ONCOLOGY | 135000 |
| 12 | Relapse Non- HodgekinLymphomaProtocol - RICE/RDHAP - 3 cycles are allowed |
IP | MEDICAL ONCOLOGY | 150000 |
| 13 | Burkitts Lymphoma - 6 cycles allowed | IP | MEDICAL ONCOLOGY | 150000 |
| 14 | Paeditricburkitts/ DLBCL lymphoma: LMB Protocol / MCGRATH protocol - 4 cycles allowed |
IP | MEDICAL ONCOLOGY | 125000 |
| 15 | Paediatric ALCL : BFM NHL Protocol - 6 cycles allowed | IP | MEDICAL ONCOLOGY | 80000 |
| 16 | Chemotherapy for Hepatoblastoma with super plado - for every 15 days upto 6 cycles |
IP | MEDICAL ONCOLOGY | 5000 |
| 17 | AML ealderly (more than 60 yrs) / not fit for intensive theraphy; Decitabine / azacytidine |
IP | MEDICAL ONCOLOGY | 40000 |
| 18 | APML- Induction | IP | MEDICAL ONCOLOGY | 370000 |
| 19 | APML - Consolidation - 4 cycles allowed | IP | MEDICAL ONCOLOGY | 60000 |
| 20 | Chemotherapy for Acute Lymphoblastic Leukaemia with Induction 1st And 2nd Months for (15 to 25 years) one time only |
IP | MEDICAL ONCOLOGY | 250000 |
| 21 | Chemotherapy for Acute Lymphoblastic Leukaemia with Induction 1st And 2nd Months for (> 25 years) one time only | IP | MEDICAL ONCOLOGY | 270000 |
| 22 | Chemotherapy for Acute Lymphoblastic Leukaemia with Induction 3rd 4th 5thfor (15 to 25 years) one time only | IP | MEDICAL ONCOLOGY | 25000 |
| 23 |
Chemotherapy for Acute Lymphoblastic Leukaemia with Induction 3rd 4th 5th for (> 25 years) one time only |
IP | MEDICAL ONCOLOGY | 30000 |
| 24 | Chemotherapy for Acute Lymphoblastic Leukaemia with Re-Induction for (< 15 years) one time only | IP | MEDICAL ONCOLOGY | 60000 |
| 25 |
Chemotherapy for Acute Lymphoblastic Leukaemia with Re-Induction for (15 to 25 years) one time only |
IP | MEDICAL ONCOLOGY | 80000 |
| 26 | Chemotherapy for Acute Lymphoblastic Leukaemia with Re-Induction for (> 25 years) one time only | IP | MEDICAL ONCOLOGY | 80000 |
| 27 | Myloma autologous HSCT | IP | MEDICAL ONCOLOGY | 650000 |
| 28 | Gemcitabine + Cisplatin - 6 cycles allowed | IP | MEDICAL ONCOLOGY | 12000 |
| 29 | Pemetrexed + carboplatin - for every 3 weeks upto 6 cycles | IP | MEDICAL ONCOLOGY | 20010 |
| 30 | Dose Dense AC (includes growth factor + apprepitant; Once in two weeks) - upto 4 cycles |
IP | MEDICAL ONCOLOGY | 10000 |
| 31 | Dose Dense Paclitaxel (includes growth factor ; Once in two weeks) - upto 4 cycles | IP | MEDICAL ONCOLOGY | 13000 |
| 32 | Chemotherapy for NET Pancreas with octreotide depot - for every 4 weeks for a period of one year |
IP | MEDICAL ONCOLOGY | 30000 |
| 33 | auto transplant for lymphomas | IP | MEDICAL ONCOLOGY | 935000 |
| 34 | Lymphoma workup | IP | MEDICAL ONCOLOGY | 20000 |
| 35 | Transplant for paediatric solid cancers (EWS, Neuro blastoma, Wilms tumour, RMS, Germcelltumour; | IP | MEDICAL ONCOLOGY | 650000 |
| 36 | MyeloDisplastic Syndrome - 6 cycles allowed | IP | MEDICAL ONCOLOGY | 40000 |
| 37 | Pet scan only for hodgkin and non hodgkin lymphoma (Only two pet scans) in entire course. - Maximum 2 pet scans are allowed | IP | MEDICAL ONCOLOGY | 15000 |
| 38 | Palliative Chemotherapy with paclitaxel/Carboplatin - for every 3 weeks upto 6 cycles | IP | MEDICAL ONCOLOGY | 11000 |
| 39 | Palliative Chemotherapy with TPF regimen - for every 3 weeks upto 6 cycles | IP | MEDICAL ONCOLOGY | 18000 |
| 40 | Palliative Chemotherapy with Gemcitabina/Cisplatin - for every 3 weeks upto 6 cycles | IP | MEDICAL ONCOLOGY | 15000 |
| 41 | Weekly paclitaxel - Per week | IP | MEDICAL ONCOLOGY | 4000 |
| 42 | Docetaxel + Cyclophosphamide (includes groth factor) - for every 3 weeks upto 4 cycles |
IP | MEDICAL ONCOLOGY | 12000 |
| 43 | IGRT:List of Diseases - 1. CA Prostate non metastatic2. CA Lung non metastatic (minimum of 6600cGy in 33 fractions or its equivalent) | IP | RADIATION ONCOLOGY | 275000 |
| 44 | I-131 Radio iodine ablation therapy for Thyroid Malignancies (For every 50 milli curie given dose in each application) | IP | RADIATION ONCOLOGY | 30000 |
| 45 | Palliative - Specialized Radiation therapy - 3DCRT(3- D conformational radiotherapy)Upto 30 Fractions 3DCRT In 6 Weeks |
IP | RADIATION ONCOLOGY | 60000 |
| 46 | Adjuvant - Specialized Radiation therapy - 3DCRT(3- D conformational radiotherapy)Upto 30 Fractions 3DCRT In 6 Weeks |
IP | RADIATION ONCOLOGY | 75000 |
